Detalhe da pesquisa
1.
How to use prior knowledge and still give new data a chance?
Pharm Stat
; 17(4): 329-341, 2018 07.
Artigo
Inglês
| MEDLINE | ID: mdl-29667367
2.
Generating the Right Evidence at the Right Time: Principles of a New Class of Flexible Augmented Clinical Trial Designs.
Clin Pharmacol Ther
; 113(5): 1132-1138, 2023 05.
Artigo
Inglês
| MEDLINE | ID: mdl-36757107
3.
Application of Bayesian approaches in drug development: starting a virtuous cycle.
Nat Rev Drug Discov
; 22(3): 235-250, 2023 03.
Artigo
Inglês
| MEDLINE | ID: mdl-36792750
4.
Assessing the impact of ICH E9.
Pharm Stat
; 7(2): 77-87, 2008.
Artigo
Inglês
| MEDLINE | ID: mdl-18438957
5.
Conditional approval: discussion points from the PSI conditional approval expert group.
Pharm Stat
; 7(4): 263-9; discussion 270-1, 2008.
Artigo
Inglês
| MEDLINE | ID: mdl-17847030
6.
Under a Black Cloud Glimpsing a Silver Lining: Comment on Statistical Issues and Recommendations for Clinical Trials Conducted During the COVID-19 Pandemic.
Stat Biopharm Res
; 12(4): 414-418, 2020 Jul 14.
Artigo
Inglês
| MEDLINE | ID: mdl-34191973
7.
Is it time to abandon complete blinded independent central radiological evaluation of progression in registration trials?
Eur J Cancer
; 47(12): 1759-62, 2011 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-21641204